Bluejay Diagnostics Inc
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnos… Read more
Bluejay Diagnostics Inc (BJDX) - Total Liabilities
Latest total liabilities as of December 2025: $1.14 Million USD
Based on the latest financial reports, Bluejay Diagnostics Inc (BJDX) has total liabilities worth $1.14 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bluejay Diagnostics Inc - Total Liabilities Trend (2019–2025)
This chart illustrates how Bluejay Diagnostics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bluejay Diagnostics Inc Competitors by Total Liabilities
The table below lists competitors of Bluejay Diagnostics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Getty Copper Inc
PINK:GTCDF
|
USA | $3.55 Million |
|
Go Green Global Tech
OTCQB:GOGR
|
USA | $1.60 Million |
|
Michman Basad Ltd
TA:MCMN
|
Israel | ILA847.65 Million |
|
Mobile Global Esports Inc.
NASDAQ:MGAM
|
USA | $768.73K |
|
SIMPSON MANUFACTRNG
MU:TWL
|
Germany | €1.01 Billion |
|
MITSUI MNG & SMLT
DU:MMG
|
Germany | €310.01 Billion |
|
Bless Asset Group PCL
BK:BLESS
|
Thailand | ฿1.07 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Bluejay Diagnostics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bluejay Diagnostics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bluejay Diagnostics Inc (2019–2025)
The table below shows the annual total liabilities of Bluejay Diagnostics Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.14 Million | +23.28% |
| 2024-12-31 | $927.92K | -52.99% |
| 2023-12-31 | $1.97 Million | -0.32% |
| 2022-12-31 | $1.98 Million | +210.75% |
| 2021-12-31 | $637.16K | -88.87% |
| 2020-12-31 | $5.72 Million | +48.70% |
| 2019-12-31 | $3.85 Million | -- |